Page last updated: 2024-08-22

vidarabine and Abnormalities, Multiple

vidarabine has been researched along with Abnormalities, Multiple in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adachi, K; Hirabayashi, K; Koike, K; Nakazawa, Y; Nanba, E; Saito, S; Sakai, N; Sakashita, K; Shibazaki, T; Shigemura, T; Shiohara, M; Takagi, M	1
Hanke, A; Lohse, P; Meissner, B; Rehe, K; Sauer, M; Sykora, KW; Welte, K; Zeidler, C	1
Bhatla, D; Bleesing, J; Crockett, M; Davies, SM; Filipovich, AH; Hansen, M; Harris, RE; Jodele, S; Jordan, M; Mehta, PA; Shenoy, S; Shoultz, L; Smolarek, T	1

Trials

1 trial(s) available for vidarabine and Abnormalities, Multiple

Article	Year
Substitution of cyclophosphamide and busulfan by fludarabine, treosulfan and melphalan in a preparative regimen for children and adolescents with Shwachman-Diamond syndrome. Bone marrow transplantation, 2007, Volume: 39, Issue:3 Topics: Abnormalities, Multiple; Adolescent; Bone Marrow Diseases; Busulfan; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Melphalan; Pilot Projects; Syndrome; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine	2007

Article

Year

Substitution of cyclophosphamide and busulfan by fludarabine, treosulfan and melphalan in a preparative regimen for children and adolescents with Shwachman-Diamond syndrome.

Bone marrow transplantation, 2007, Volume: 39, Issue:3

Topics: Abnormalities, Multiple; Adolescent; Bone Marrow Diseases; Busulfan; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Melphalan; Pilot Projects; Syndrome; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine

2007

Other Studies

2 other study(ies) available for vidarabine and Abnormalities, Multiple

Article	Year
Clinical and laboratory outcomes after umbilical cord blood transplantation in a patient with mucolipidosis II alpha/beta. American journal of medical genetics. Part A, 2016, Volume: 170A, Issue:5 Topics: Abnormalities, Multiple; Animals; Child, Preschool; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Female; Humans; Immunoglobulins; Mucolipidoses; Psychomotor Disorders; Rabbits; Transferases (Other Substituted Phosphate Groups); Transplantation, Homologous; Vidarabine	2016
Reduced-intensity conditioning is effective and safe for transplantation of patients with Shwachman-Diamond syndrome. Bone marrow transplantation, 2008, Volume: 42, Issue:3 Topics: Abnormalities, Multiple; Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Child; Child, Preschool; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Male; Melphalan; Pancreatic Diseases; Stem Cell Transplantation; Transplantation Conditioning; Vidarabine	2008

Article

Year

Clinical and laboratory outcomes after umbilical cord blood transplantation in a patient with mucolipidosis II alpha/beta.

American journal of medical genetics. Part A, 2016, Volume: 170A, Issue:5

Topics: Abnormalities, Multiple; Animals; Child, Preschool; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Female; Humans; Immunoglobulins; Mucolipidoses; Psychomotor Disorders; Rabbits; Transferases (Other Substituted Phosphate Groups); Transplantation, Homologous; Vidarabine

2016

Reduced-intensity conditioning is effective and safe for transplantation of patients with Shwachman-Diamond syndrome.

Bone marrow transplantation, 2008, Volume: 42, Issue:3

Topics: Abnormalities, Multiple; Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Child; Child, Preschool; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Male; Melphalan; Pancreatic Diseases; Stem Cell Transplantation; Transplantation Conditioning; Vidarabine

2008